The mortality rate for ovary malignant neoplasms in Mexico, expressed in female deaths per hundred thousand women, exhibits a gradual increasing trend from 4.9 in 2024 to 5.4 in 2028. This reflects a consistent year-on-year percentage increase, with values rising from an actual rate of 4.8 in 2023. The year-on-year variations are steady, culminating in a Compound Annual Growth Rate (CAGR) averaging approximately 2.5% per year over the forecasted period.
Future trends to watch for include potential impacts of advancements in medical treatments and technologies, public health initiatives targeted at early detection, and broader socio-economic factors. Monitoring these elements will be crucial for predicting future mortality rates and preparing adequate health response plans.
